Inside the research

Tenet Healthcare Corporation

THC Research profile · latest available data

Price overview

$259.71

▲ +10.17 (+4.1%)

52w hi$280.77
52w lo$161.37
Vol735.10K
As of25 Sep 2026

The Verdict

Buy

Our score +0.52

Short+0.31
Medium+0.65
Long+0.68

computed 2026-09-27

Key fundamentals

Tenet Healthcare Corporation

Healthcare · Medical Care Facilities

Market cap$20.91B
Enterprise value$36.03B
Trailing P/E10.04x
Forward P/E12.31x
EV / EBITDA7.44x
P / S (ttm)0.96x
Profit margin10.3%
Return on equity37.3%
Revenue growth+6.8%
Earnings growth+213.4%
Debt / equity152.28

Layer Breakdown

LayerRawContribution
Fundamental+0.37
Sector+0.08
Technical+0.28
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

United States · www.tenethealth.com

Risk Metrics

Beta vs SPX0.83
Corr SPX0.30
Annual vol44.0%
Annual ret+32.1%
Sharpe0.73
Max DD-34.5%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$245.52
High / Low$288.00 / $210.00
Median$245.00
Analysts21
Strong Buy6
Buy14
Hold2
Sell0
Strong Sell0

Recent rating actions

2026-05-05Barclays→ Overweight
2026-05-05Baird→ Neutral
2026-05-04Stephens & Co.→ Overweight
2026-05-01Wells Fargo→ Overweight
2026-05-01RBC Capital→ Outperform
2026-05-01Keybanc→ Overweight

Material Events

DateEvent8-K
2026-07-23Earnings Release, Exhibitsread
2026-05-29Shareholder Voteread
2026-04-30Earnings Release, Exhibitsread
2026-04-10Officer / Director Change, Exhibitsread
2026-03-30Officer / Director Change, Exhibitsread
2026-02-11Earnings Release, Exhibitsread
2026-02-02Earnings Release, Reg FD Disclosure…read
2025-11-24Officer / Director Changeread
2025-11-18Material Agreement, Material Obligation…read
2025-11-05Material Agreement, Material Obligation…read
2025-11-03Reg FD Disclosure, Other Material Event…read
2025-10-28Earnings Release, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders9
Top-5 share95.2%
HHI2,414 (moderate)

Top Holders

HolderValueShares
Fidelity / FMR LLC$747.30M3.99M
State Street Corp$514.71M2.75M
Citadel Advisors$394.29M2.11M
AQR Capital Management$198.27M1.07M
Capital Research / Capital World$121.57M649.85K
Millennium Management$89.29M477.29K
Bridgewater Associates$7.93M42.38K
Norges Bank (Norway sovereign)$1.71M9.13K
T. Rowe Price Group$1.49M7.96M

As of 2026-06-30

Dividends

Yield (TTM)0.00%
$ / share (TTM)$0.00
5y CAGR—

Annual dividend per share

1989$0.93
1990$3.51
1991$1.15
1992$1.25
1993$0.96
2000$0.03

SEC Filings

DateFormDoc
2026-08-104view
2026-08-074view
2026-07-314view
2026-07-2910-Qview
2026-07-284view
2026-07-284view
2026-07-284view
2026-07-238-Kview
2026-05-298-Kview
2026-05-294view
2026-05-284view
2026-05-284view
2026-05-284view
2026-05-284view
2026-05-284view

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$20.68B-0.3%
Operating income$2.51B+10.8%
Cash from ops$2.05B+16.5%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$248.89$260.97$248.86$259.71735.10K
Sep 24$258.55$259.51$249.38$249.54575.80K
Sep 23$262.55$263.97$255.41$256.44631.60K
Sep 22$263.06$265.20$261.30$262.06781.90K
Sep 21$261.93$263.58$258.02$260.97670.80K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →